2.Usefulness of Comorbidity Indices in Operative Gastric Cancer Cases.
Se Min HWANG ; Seok Jun YOON ; Hyeong Sik AHN ; Hyong Gin AN ; Sang Hoo KIM ; Min Ho KYEONG ; Eun Kyoung LEE
Journal of Preventive Medicine and Public Health 2009;42(1):49-58
OBJECTIVES: The purpose of the current study was to evaluate the usefulness of the following four comorbidity indices in gastric cancer patients who underwent surgery: Charlson Comorbidity Index (CCI), Cumulative Illness rating scale (CIRS), Index of Co-existent Disease (ICED), and Kaplan-Feinstein Scale (KFS). METHODS: The study subjects were 614 adults who underwent surgery for gastric cancer at K hospital between 2005 and 2007. We examined the test-retest and inter-rater reliability of 4 comorbidity indices for 50 patients. Reliability was evaluated with Spearman rho coefficients for CCI and CIRS, while Kappa values were used for the ICED and KFS indices. Logistic regression was used to determine how these comorbidity indices affected unplanned readmission and death. Multiple regression was used for determining if the comorbidity indices affected length of stay and hospital costs. RESULTS: The test-retest reliability of CCI and CIRS was substantial (Spearman rho=0.746 and 0.775, respectively), while for ICED and KFS was moderate (Kappa=0.476 and 0.504, respectively). The inter-rater reliability of the CCI, CIRS, and ICED was moderate (Spearman rho=0.580 and 0.668, and Kappa=0.433, respectively), but for KFS was fair (Kappa=0.383). According to the results from logistic regression, unplanned readmissions and deaths were not significantly different between the comorbidity index scores. But, according to the results from multiple linear regression, the CIRS group showed a significantly increased length of hospital stay (p<0.01). Additionally, CCI showed a significant association with increased hospital costs (p<0.01). CONCLUSIONS: This study suggests that the CCI index may be useful in the estimation of comorbidities associated with hospital costs, while the CIRS index may be useful where estimatation of comorbiditie associated with the length of hospital stay are concerned.
Adult
;
Aged
;
Comorbidity/trends
;
Data Interpretation, Statistical
;
Gastrectomy
;
Humans
;
Length of Stay
;
Logistic Models
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Statistics, Nonparametric
;
Stomach/pathology
;
Stomach Neoplasms/*epidemiology/mortality/pathology/surgery
3.Re-emergence of chronic obstructive pulmonary disease: it is time to think COPDifferently.
Singapore medical journal 2013;54(12):673-677
Knowledge of chronic obstructive pulmonary disease (COPD) as a common, preventable and treatable condition has advanced in the last two decades, as evidenced by the increase in scientific literature. Tobacco smoking still remains a predominant risk factor for COPD. Thus smoking cessation management should be obligatory in every case. Although spirometry is integral to the diagnosis of COPD, one should also be aware of its limitations. COPD is a chronic disease associated with comorbidities that define its extrapulmonary manifestations. Systemic inflammation provides the biological link, while exacerbations play a prominent role in the current approach to disease evaluation. This paper reviews the latest Global Initiative for Chronic Obstructive Pulmonary Disease revision, focusing on the paradigm shift in assessment that would directly influence therapeutic decisions. Also discussed are the newer drugs and combinations of existing inhaler therapies that now present clinicians with more options, as well as bronchoscopic interventions that may perhaps offer a lower-morbidity alternative than surgical lung volume reduction. Finally, this review highlights how integrated care models can bridge the gap between components and complete a comprehensive sphere of COPD care.
Comorbidity
;
Humans
;
Inflammation
;
Pulmonary Disease, Chronic Obstructive
;
diagnosis
;
physiopathology
;
therapy
;
Pulmonary Medicine
;
methods
;
standards
;
trends
;
Risk Factors
;
Smoking
;
adverse effects
;
Spirometry
;
Treatment Outcome
4.Improving Survival Rate of Korean Patients Initiating Dialysis.
Jung Hwa RYU ; Hyunwook KIM ; Kyoung Hoon KIM ; Hoo Jae HANN ; Hyeong Sik AHN ; Shina LEE ; Seung Jung KIM ; Duk Hee KANG ; Kyu Bok CHOI ; Dong Ryeol RYU
Yonsei Medical Journal 2015;56(3):666-675
PURPOSE: The aim of this study was to investigate whether the survival rate among Korean dialysis patients changed during the period between 2005 and 2008 in Korea. MATERIALS AND METHODS: A total of 32357 patients who began dialysis between January 1, 2005 and December 31, 2008 were eligible for analysis. Baseline demographics, comorbidities, and mortality data were obtained from the database of the Health Insurance Review & Assessment Service. RESULTS: Kaplan-Meier curves according to the year of dialysis initiation showed that the survival rate was significantly different (log-rank test, p=0.005), most notably among peritoneal dialysis (PD) patients (p<0.001), although not among hemodialysis (HD) patients (p=0.497). In multivariate analysis, however, patients initiating either HD or PD in 2008 also had a significantly lower risk of mortality compared to those who began dialysis in 2005. Subgroup survival analysis among patients initiating dialysis in 2008 revealed that the survival rate of PD patients was significantly higher than that of HD patients (p=0.001), and the survival benefit of PD over HD remained in non-diabetic patients aged less than 65 years after adjustment of covariates. CONCLUSION: Survival of Korean patients initiating dialysis from 2005 to 2008 has improved over time, particularly in PD patients. In addition, survival rates among patients initiating dialysis in 2008 were different according to patients' age and diabetes, thus we need to consider these factors when dialysis modality should be chosen.
Adult
;
Aged
;
Comorbidity
;
Female
;
Humans
;
Kaplan-Meier Estimate
;
Kidney Failure, Chronic/*mortality/therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Peritoneal Dialysis/*statistics & numerical data
;
Registries
;
Renal Dialysis/*statistics & numerical data
;
Republic of Korea/epidemiology
;
Risk
;
Survival Analysis
;
Survival Rate/*trends
;
Treatment Outcome
5.Trends in the Leading Causes of Death in Korea, 1983-2012.
Daroh LIM ; Mina HA ; Inmyung SONG
Journal of Korean Medical Science 2014;29(12):1597-1603
This study aimed to analyze trends in the 10 leading causes of death in Korea from 1983 to 2012. Death rates were derived from the Korean Statistics Information Service database and age-adjusted to the 2010 population. Joinpoint regression analysis was used to identify the points when statistically significant changes occurred in the trends. Between 1983 and 2012, the age-standardized death rate (ASR) from all causes decreased by 61.6% for men and 51.2% for women. ASRs from malignant neoplasms, diabetes mellitus, and transport accidents increased initially before decreasing. ASRs from hypertensive diseases, heart diseases, cerebrovascular diseases and diseases of the liver showed favorable trends (ASR % change: -94.4%, -53.8%, -76.0%, and -78.9% for men, and -77.1%, -36.5%, -67.8%, and -79.9% for women, respectively). ASRs from pneumonia decreased until the mid-1990s and thereafter increased. ASRs from intentional self-harm increased persistently since around 1990 (ASR % change: 122.0% for men and 217.4% for women). In conclusion, death rates from all causes in Korea decreased significantly in the last three decades except in the late 1990s. Despite the great strides made in the overall mortality, temporal trends varied widely by cause. Mortality trends for malignant neoplasms, diabetes mellitus, pneumonia and intentional self-harm were unfavorable.
Accidents, Traffic
;
Adult
;
Age Distribution
;
Aged
;
Aged, 80 and over
;
Cardiovascular Diseases/*mortality
;
Causality
;
Cause of Death/*trends
;
Comorbidity
;
*Data Interpretation, Statistical
;
Female
;
Humans
;
Liver Diseases/*mortality
;
Male
;
Middle Aged
;
Neoplasms/*mortality
;
Republic of Korea/epidemiology
;
Respiration Disorders/*mortality
;
Sex Distribution
;
Young Adult